Concepedia
Statistics
Publications
5
Citations
222
H-Index
Active since
2004
Affiliations
Novartis (Switzerland)(Current)
Novartis Institutes for BioMedical Research
Ernst Blum is an author at Novartis (Switzerland) specializing in medicinal chemistry, drug discovery, and pharmacology.
Publications per year
2004–2018
Pyrazoloheteroaryls: Novel p38α MAP kinase inhibiting scaffolds with oral activity
Láśzló Révész, Ernst Blum, Franco E. Di Padova et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 77 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +11
Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis
Láśzló Révész, Ernst Blum, Franco E. Di Padova et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 61 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +11
SAR of benzoylpyridines and benzophenones as p38α MAP kinase inhibitors with oral activity
Láśzló Révész, Ernst Blum, Franco E. Di Padova et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 33 citations · Full text
Synthesis of novel piperazine based building blocks: 3,7,9-triazabicyclo[3.3.1]nonane, 3,6,8-triazabicyclo[3.2.2]nonane, 3-oxa-7,9-diazabicyclo[3.3.1]nonane and 3-oxa-6,8-diazabicyclo[3.2.2]nonane
Láśzló Révész, Ernst Blum, Reto Wicki · Tetrahedron Letters · 2005 · 29 citations
Natural Sciences, Chemistry, Medicinal Chemistry +10
Modulating ADME Properties by Fluorination: MK2 Inhibitors with Improved Oral Exposure
Juraj Velcicky, Achim Schlapbach, Richard Heng et al. · ACS Medicinal Chemistry Letters · 2018 · 22 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +10
1–5 of 5